Navigation Links
Elekta's Leksell Gamma Knife Perfexion Earns Nearly Perfect Score in 2011 KLAS Radiation Therapy Report

ATLANTA, Dec. 9, 2011 /PRNewswire/ -- With a score of 94.4 out of 100, Elekta's Leksell Gamma Knife® Perfexion™ is "practically perfect in every way," ranking at the top among six advanced radiation therapy systems, according to KLAS research firm's recently released customer survey, Radiation Therapy 2011: A Dose of New Technology. The Elekta Infinity™ radiation treatment system garnered the #2 ranking with a score of 84.4, improving its score over the 2010 report.

The 2011 KLAS report – the result of interviews with 213 U.S. provider organizations – referenced respondents' regard for the Perfexion system's technological sophistication, making "treating very complicated tumors in a difficult spot easy for providers," and for the radiosurgery platform's unprecedented uptime statistics. The report summarized customer opinion by noting: "The speed, accuracy, reliability, and sophistication of the treatments all came together for the Gamma Knife Perfexion to earn the highest score in the study by a 10-point margin."

Gamma Knife® surgery is a gentler alternative to traditional brain surgery for illnesses such as metastatic disease – cancer that has traveled to the brain from elsewhere in the body. The system delivers thousands of low-intensity radiation beams to one or more targets in a single session. Leksell Gamma Knife Perfexion provides even greater speed and ease of use than previous versions, especially for treating multiple metastases.

Supported by three decades of clinical practice in both neurosurgery and radiation oncology departments, more than 50,000 patients each year are treated with Gamma Knife surgery.

*Radiation Therapy 2011: A Dose of New Technology, © November, 2011 KLAS Enterprises, LLC. All rights reserved.

About Elekta
Elekta is a human care company pioneering significant innovations and clinical solutions for treating cancer and brain disorders. The company develops sophisticated, state-of-the-art tools and treatment planning systems for radiation therapy, radiosurgery and brachytherapy, as well as workflow enhancing software systems across the spectrum of cancer care. Stretching the boundaries of science and technology, providing intelligent and resource-efficient solutions that offer confidence to both healthcare providers and patients, Elekta aims to improve, prolong and even save patient lives.

Today, Elekta solutions in oncology and neurosurgery are used in over 6,000 hospitals worldwide. Elekta employs around 3,300 employees globally. The corporate headquarters is located in Stockholm, Sweden, and the company is listed on the Nordic Exchange under the ticker EKTAb. Website:




Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Elektas Leksell Gamma Knife Perfexion is Ranked 2011s Best in KLAS for Radiation Therapy
2. Elekta Emphasizes Advantages of Leksell Gamma Knife Perfexion Over Competing Systems at 2011 AANS Meeting
3. Treatment with Elektas Leksell Gamma Knife Perfexion Introduced to Cancer Patients in Australia
4. Islanders and Tourists with Brain Cancer to Benefit from Hawaiian Centers Installment of Elektas Leksell Gamma Knife Perfexion
5. Physicians See New Benefits, Treatment Opportunities for Brain Cancer with Elektas Leksell Gamma Knife Perfexion
6. Karolinska University Hospital Acquires Leksell Gamma Knife Perfexion to Expand Radiosurgery Versatility, Efficiency in Brain Cancer Therapy
7. University of Pittsburgh Medical Center (UPMC) Treats 10,000th Patient with Leksell Gamma Knife Radiosurgery System
8. Saint Josephs Hospital First in Georgia to Offer Noninvasive Treatment of Brain Disorders with Leksell Gamma Knife Perfexion
9. Elekta Announces Clinical Start-Up of New Leksell Gamma Knife(R) Perfexion(TM) at UPMC
10. Global Gamma/Scintillation Cameras Industry
11. Gamma Pharmaceuticals, Inc., Launches Retail Promotions for Gamma Energy Gel™ in New York City and Houston
Post Your Comments:
(Date:11/25/2015)... 25, 2015 Endo International plc (NASDAQ: ENDP ... , President and CEO, will discuss corporate updates at the ... New York on Wednesday, December 2, 2015 ... on Investor Relations, and then the link to the event. ... start time to visit the site and download any streaming ...
(Date:11/25/2015)... 2015 Asia -based ... BioLight and the New Investors will make a direct ... a private placement. The financing will help IOPtima to ... used in the treatment of glaucoma, as well as ... IOPtimate™ system with the U.S. Food and Drug Administration, ...
(Date:11/25/2015)... 2015 - Will Also Offer ... (CME) --> - Will Also ... (CME) --> - Will ... Medical Education (CME) Elsevier , a ... will feature latest diagnostic imaging textbooks and decision support tools, as ...
Breaking Medicine Technology:
(Date:11/25/2015)... ... ... Many people know of the common symptoms of low thyroid hormone (also ... many people who find their cholesterol levels and weight are creeping up are more ... they don’t have any of the other symptoms. , Thyroid hormone plays a major ...
(Date:11/25/2015)... , ... November 25, 2015 , ... ... is offering lower prices in an early celebration of the early holiday shopping ... price of $29.95 each (normally $33.95 ea). Black Friday promotional pricing is in ...
(Date:11/24/2015)... ... ... New patients who wish to seek treatment for missing teeth can now ... Mississauga, ON practice. Dr. Williams has been providing dental service for over 34 years, ... teeth can lead to a variety of complications if they are not replaced quickly, ...
(Date:11/24/2015)... ... November 24, 2015 , ... In an article ... variables that determine which patients are or are not eligible for bariatric surgery. The ... BMI over 40, are more than 100 pounds overweight, or have a BMI of ...
(Date:11/24/2015)... ... , ... Preparing for the LDT Regulation:, CLIA Won’t Satisfy the FDA, ... FDA has long asserted that design and manufacture of Laboratory Developed Tests (LDTs) falls ... meet the device regulations. , Come up short in an inspection and the FDA ...
Breaking Medicine News(10 mins):